IL-6 and CD8+ T cell counts combined are an early predictor of in-hospital mortality of patients with COVID-19.
Aged
Area Under Curve
Betacoronavirus
CD8-Positive T-Lymphocytes
COVID-19
Coronavirus Infections
/ blood
Female
Hospital Mortality
Humans
Interleukin-10
/ immunology
Interleukin-6
/ immunology
Interleukin-8
/ immunology
Logistic Models
Lymphocyte Count
Lymphopenia
/ blood
Male
Middle Aged
Multivariate Analysis
Pandemics
Pneumonia, Viral
/ blood
Prognosis
ROC Curve
Receptors, Interleukin-2
/ immunology
Retrospective Studies
SARS-CoV-2
Tumor Necrosis Factor-alpha
/ immunology
Cytokines
Infectious disease
Pulmonology
T cells
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
09 07 2020
09 07 2020
Historique:
received:
13
04
2020
accepted:
03
06
2020
pubmed:
17
6
2020
medline:
18
7
2020
entrez:
17
6
2020
Statut:
epublish
Résumé
BACKGROUNDFatal cases of COVID-19 are increasing globally. We retrospectively investigated the potential of immunologic parameters as early predictors of COVID-19.METHODSA total of 1018 patients with confirmed COVID-19 were enrolled in our 2-center retrospective study. Clinical feature, laboratory test, immunological test, radiological findings, and outcomes data were collected. Univariate and multivariable logistic regression analyses were performed to evaluate factors associated with in-hospital mortality. Receiver operator characteristic (ROC) curves and survival curves were plotted to evaluate their clinical utility.RESULTSThe counts of all T lymphocyte subsets were markedly lower in nonsurvivors than in survivors, especially CD8+ T cells. Among all tested cytokines, IL-6 was elevated most significantly, with an upward trend of more than 10-fold. Using multivariate logistic regression analysis, IL-6 levels of more than 20 pg/mL and CD8+ T cell counts of less than 165 cells/μL were found to be associated with in-hospital mortality after adjusting for confounding factors. Groups with IL-6 levels of more than 20 pg/mL and CD8+ T cell counts of less than 165 cells/μL had a higher percentage of older and male patients as well as a higher proportion of patients with comorbidities, ventilation, intensive care unit admission, shock, and death. Furthermore, the receiver operating curve of the model combining IL-6 (>20 pg/mL) and CD8+ T cell counts (<165 cells/μL) displayed a more favorable discrimination than that of the CURB-65 score. The Hosmer-Lemeshow test showed a good fit of the model, with no statistical significance.CONCLUSIONIL-6 (>20 pg/mL) and CD8+ T cell counts (<165 cells/μL) are 2 reliable prognostic indicators that accurately stratify patients into risk categories and predict COVID-19 mortality.FundingThis work was supported by funding from the National Natural Science Foundation of China (no. 81772477 and 81201848).
Identifiants
pubmed: 32544099
pii: 139024
doi: 10.1172/jci.insight.139024
pmc: PMC7406244
doi:
pii:
Substances chimiques
CXCL8 protein, human
0
IL10 protein, human
0
IL6 protein, human
0
Interleukin-6
0
Interleukin-8
0
Receptors, Interleukin-2
0
TNF protein, human
0
Tumor Necrosis Factor-alpha
0
Interleukin-10
130068-27-8
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
ASAIO J. 2020 Jul;66(7):722-730
pubmed: 32317557
Cell Host Microbe. 2016 Feb 10;19(2):181-93
pubmed: 26867177
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Clin Microbiol Infect. 2015 Jun;21(6):608.e1-8
pubmed: 25704448
Clin Infect Dis. 2019 Mar 5;68(6):984-992
pubmed: 30060038
BMJ. 2009 Jun 29;338:b2393
pubmed: 19564179
JAMA. 2020 Feb 7;:
pubmed: 32031570
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975
pubmed: 32350134
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Blood Adv. 2020 Apr 14;4(7):1307-1310
pubmed: 32243501
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Clin Infect Dis. 2009 Jun 15;48(12):1796; author reply 1796-7
pubmed: 19473089
J Virol. 2016 Dec 16;91(1):
pubmed: 27795435
Clin Lab. 2008;54(5-6):179-83
pubmed: 18780664
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Br J Haematol. 2020 May;189(3):428-437
pubmed: 32297671
Sci Immunol. 2017 Aug 4;2(14):
pubmed: 28778905
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Thorax. 2003 May;58(5):377-82
pubmed: 12728155
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):203-208
pubmed: 32164089
Science. 2013 Jun 7;340(6137):1230-4
pubmed: 23618765
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452